Works by GABELLIERI, ENRICO

Results: 5

Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY).
Published in:
Acta Diabetologica, 2022, v. 59, n. 10, p. 1317, doi. 10.1007/s00592-022-01925-9
By:
- Fadini, Gian Paolo;
- Buzzetti, Raffaella;
- Nicolucci, Antonio;
- Larosa, Monica;
- Rossi, Maria Chiara;
- Cucinotta, Domenico;
- On behalf of the RESTORE-2 Study Group;
- Enrico, Gabellieri;
- Alberto, Marangoni;
- Uberto, Pagotto;
- Claudio, Bongiorno;
- Concetta, Gatta;
- Andrea, Del Buono;
- Olga, Lamacchia;
- Pasquale, Maiellaro;
- Daniela, Antenucci;
- Gabriele, Brandoni;
- Francesca, Borroni;
- Giovanna, Gregori;
- Antonino, Di Benedetto
Publication type:
Article
COVID19 infection and vaccination and the risk of pituitary apoplexy: an entangled yarn.
Published in:
Endocrine (1355008X), 2025, v. 87, n. 2, p. 459, doi. 10.1007/s12020-024-04078-7
By:
- Ragni, Alberto;
- Biamonte, Emilia;
- Cavigiolo, Beatrice;
- Mollero, Edoardo Luigi Maria;
- Bendotti, Giulia;
- Gabellieri, Enrico;
- Leporati, Paola;
- Gallo, Marco
Publication type:
Article
Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study.
Published in:
Diabetes Therapy, 2023, v. 14, n. 1, p. 77, doi. 10.1007/s13300-022-01328-7
By:
- Candido, Riccardo;
- Modugno, Monica;
- Larosa, Monica;
- Rossi, Maria Chiara;
- Nicolucci, Antonio;
- Gabellieri, Enrico
Publication type:
Article
The Gastric CB1 Receptor Modulates Ghrelin Production through the mTOR Pathway to Regulate Food Intake.
Published in:
PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0080339
By:
- Senin, Lucia L.;
- Al-Massadi, Omar;
- Folgueira, Cintia;
- Castelao, Cecilia;
- Pardo, Maria;
- Barja-Fernandez, Silvia;
- Roca-Rivada, Arturo;
- Amil, Maria;
- Crujeiras, Ana B.;
- Garcia-Caballero, Tomas;
- Gabellieri, Enrico;
- Leis, Rosaura;
- Dieguez, Carlos;
- Pagotto, Uberto;
- Casanueva, Felipe F.;
- Seoane, Luisa M.
Publication type:
Article
110-LB: Efficacy, Safety, and Appropriateness of iGlarLixi, a Fixed-Ratio Combination (FRC) in Type 2 Diabetes (T2D) in Real-World Settings: Results from the ENSURE Study.
Published in:
Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-110-LB
By:
- CANDIDO, RICCARDO;
- MODUGNO, MONICA;
- GABELLIERI, ENRICO;
- NICOLUCCI, ANTONIO;
- ROSSI, MARIA CHIARA;
- LAROSA, MONICA
Publication type:
Article

Works by GABELLIERI, ENRICO

Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY).

COVID19 infection and vaccination and the risk of pituitary apoplexy: an entangled yarn.

Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study.

The Gastric CB1 Receptor Modulates Ghrelin Production through the mTOR Pathway to Regulate Food Intake.

110-LB: Efficacy, Safety, and Appropriateness of iGlarLixi, a Fixed-Ratio Combination (FRC) in Type 2 Diabetes (T2D) in Real-World Settings: Results from the ENSURE Study.